- Home
- MRNA vs TLN Comparison
MRNA vs TLN Comparison
Compare MRNA & TLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- TLN
- Stock Information
- Founded
- MRNA 2010
- TLN 2015
- Country
- MRNA United States
- TLN United States
- Employees
- MRNA N/A
- TLN N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- TLN Electric Utilities: Central
- Sector
- MRNA Health Care
- TLN Utilities
- Exchange
- MRNA Nasdaq
- TLN Nasdaq
- Market Cap
- MRNA 10.3B
- TLN 9.7B
- IPO Year
- MRNA 2018
- TLN N/A
- Fundamental
- Price
- MRNA $30.28
- TLN $276.27
- Analyst Decision
- MRNA Hold
- TLN Strong Buy
- Analyst Count
- MRNA 19
- TLN 12
- Target Price
- MRNA $48.13
- TLN $256.33
- AVG Volume (30 Days)
- MRNA 9.3M
- TLN 1.2M
- Earning Date
- MRNA 07-31-2025
- TLN 08-12-2025
- Dividend Yield
- MRNA N/A
- TLN N/A
- EPS Growth
- MRNA N/A
- TLN 50.75
- EPS
- MRNA N/A
- TLN 10.79
- Revenue
- MRNA $3,177,000,000.00
- TLN $2,087,000,000.00
- Revenue This Year
- MRNA N/A
- TLN $9.94
- Revenue Next Year
- MRNA $9.70
- TLN $23.87
- P/E Ratio
- MRNA N/A
- TLN $25.60
- Revenue Growth
- MRNA N/A
- TLN N/A
- 52 Week Low
- MRNA $23.15
- TLN $98.50
- 52 Week High
- MRNA $129.39
- TLN $301.70
- Technical
- Relative Strength Index (RSI)
- MRNA 67.06
- TLN 53.77
- Support Level
- MRNA $26.81
- TLN $282.91
- Resistance Level
- MRNA $28.24
- TLN $301.70
- Average True Range (ATR)
- MRNA 1.24
- TLN 9.16
- MACD
- MRNA 0.34
- TLN -2.15
- Stochastic Oscillator
- MRNA 93.38
- TLN 15.12
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About TLN Talen Energy Corporation Common Stock
Talen Energy Corp is an independent power producer and energy infrastructure company. The company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States. The group produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, including PJM and WECC, with its generation fleet located in the Mid-Atlantic and Montana.